Back
Bruker Vs. Vaxcyte Industry Stock Comparison
Sell
16
BRKR
Bruker
Last Price:
$36.27
Seasonality Move:
2.47%
Sell
32
PCVX
Vaxcyte
Last Price:
$30.62
Seasonality Move:
22.62%
Sell
32
Vaxcyte (PCVX)
is a Sell
Is Vaxcyte a Buy, Sell or Hold?
-
PCVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRKR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.45 | Sell |
Relative Strength Index (14 RSI): | 36.16 | Sell |
Chaikin Money Flow: | -2888387 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.98 - 44.84) | Sell |
Bollinger Bands (100): | (44.46 - 59.42) | Sell |
PCVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.26 | Sell |
Relative Strength Index (14 RSI): | 26.64 | Sell |
Chaikin Money Flow: | 1670680 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29 - 70.58) | Sell |
Bollinger Bands (100): | (57 - 95.4) | Sell |
BRKR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.35 | Sell |
20-day SMA: | 40.2 | Sell |
50-day SMA: | 45.8 | Sell |
200-day SMA: | 57.54 | Sell |
8-day EMA: | 38.25 | Sell |
20-day EMA: | 40.28 | Sell |
50-day EMA: | 45.02 | Sell |
200-day EMA: | 56.18 | Sell |
PCVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.29 | Buy |
20-day SMA: | 43.49 | Sell |
50-day SMA: | 64.67 | Sell |
200-day SMA: | 86.06 | Sell |
8-day EMA: | 31.75 | Sell |
20-day EMA: | 41.54 | Sell |
50-day EMA: | 58.42 | Sell |
200-day EMA: | 76.81 | Sell |
Bruker Earnings Growth & BRKR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.24 per share, and an increase next year of $0.38 per share.
Vaxcyte Earnings Growth & PCVX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.44 per share.
Bruker Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vaxcyte Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |